Myeloma News

CHICAGO — In this video, Sandra Mazzoni, DO, highlights data in nontransplant-eligible patients with multiple myeloma presented at ASCO Annual Meeting.

CHICAGO — Sandra Mazzoni, DO, spoke with Healio about a study presented at ASCO Annual Meeting she was part of investigating the use of AI to determine any patterns in how patients with multiple myeloma respond to therapy.

CHICAGO — In this video, Sandra Mazzoni, DO, discusses the use of minimal residual disease, or MRD, testing in multiple myeloma.

People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.

FDA has scaled back its Risk Evaluation and Mitigation Strategy reporting requirements for providers of chimeric antigen receptor T-cell therapies.

Several hematologists will be honored during this year’s ASH Annual Meeting.